Template:Available forms of testosterone

From blackwiki
Revision as of 07:33, 20 October 2020 by imported>Monkbot (→‎top: Task 17 (BRFA trial): replace to-be-deprecated: |name-list-format= (2× replaced; usage: 2 of 3);)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Available forms of testosterone[lower-alpha 1]

Route Ingredient Form Dose[lower-alpha 2] Brand names[lower-alpha 3]
Oral Template:No selflink Capsule 40 mg Andriol, Jatenzo
Sublingual Template:No selflink Tablet 10 mg Testoral
Buccal Template:No selflink Tablet 30 mg Striant
Intranasal Template:No selflink Nasal gel 5.5 mg/spray, 120 sprays Natesto
Transdermal Template:No selflink Non-scrotal patch 2.5, 4, 5, 6 mg/day Androderm
Non-scrotal patch 150, 300 μg/day Intrinsa
Scrotal patch[lower-alpha 4] 4, 6 mg/day Testoderm
Topical gel 25, 50, 75, 100, 125 mg/pump AndroGel, Testim
Axillary solution 30 mg/pump Axiron
Rectal Template:No selflink Suppository 40 mg Rektandron
Injection[lower-alpha 5] Template:No selflink Oil solution 50, 100, 180, 200, 250 mg/mL Delatestryl
Template:No selflink Oil solution 50, 100, 200, 250 mg/mL Depo-Testosterone
Template:No selflink[lower-alpha 6] Oil solution 100, 250 mg/mL Sustanon
Template:No selflink Oil solution 750, 1000 mg Aveed, Nebido
Implant Template:No selflink Pellet 50, 75, 100, 200 mg Testopel
Footnotes and sources:

Template:Noteslist

Sources: [1][2][3][4][5][6][7][8][9][10][11][12][13][14]
Template documentation

See also

References

  1. ↑ Nieschlag E (September 2006). "Testosterone treatment comes of age: new options for hypogonadal men". Clin. Endocrinol. (Oxf). 65 (3): 275–81. doi:10.1111/j.1365-2265.2006.02618.x. PMID 16918944.
  2. ↑ Nieschlag E (January 2015). "Current topics in testosterone replacement of hypogonadal men". Best Pract. Res. Clin. Endocrinol. Metab. 29 (1): 77–90. doi:10.1016/j.beem.2014.09.008. PMID 25617174.
  3. ↑ Byrne M, Nieschlag E (May 2003). "Testosterone replacement therapy in male hypogonadism". J. Endocrinol. Invest. 26 (5): 481–9. doi:10.1007/bf03345206. PMID 12906378.
  4. ↑ M. Cappa; S. Cianfarani; L. Ghizzoni; S. Loche, M. Maghnie (10 December 2015). Advanced Therapies in Pediatric Endocrinology and Diabetology: Workshop, Rome, October 2014. Karger Medical and Scientific Publishers. pp. 68–. ISBN 978-3-318-05637-2.
  5. ↑ "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 26 July 2018.
  6. ↑ Shlomo Melmed (1 January 2016). Williams Textbook of Endocrinology. Elsevier Health Sciences. pp. 760–769. ISBN 978-0-323-29738-7.
  7. ↑ Patrick Lenehan (12 June 2003). Anabolic Steroids. CRC Press. pp. 108–109. ISBN 978-0-415-28029-7.
  8. ↑ Becker, Kenneth L. (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 1116, 1119, 1152, 1182–1185, 1195–1197, 2146. ISBN 978-0-7817-1750-2. Archived from the original on May 5, 2017. Unknown parameter |name-list-style= ignored (help)
  9. ↑ Nieschlag, Eberhart; Behre, Hermann M. (6 December 2012). Testosterone: Action - Deficiency - Substitution. Springer Science & Business Media. pp. 1–, 9, 298, 309–331, 349–353, 366–367. ISBN 978-3-642-72185-4. Unknown parameter |name-list-style= ignored (help)
  10. ↑ Krishna; Usha R. And Shah (1996). Menopause. Orient Blackswan. pp. 70–. ISBN 978-81-250-0910-8.
  11. ↑ Janet Brotherton (1976). Sex Hormone Pharmacology. Academic Press. pp. 18–19, 331, 336. ISBN 978-0-12-137250-7.
  12. ↑ Barbara G. Wells; Joseph T. DiPiro; Terry L. Schwinghammer; Cecily V. DiPiro (22 August 2014). Pharmacotherapy Handbook, 9/E. McGraw-Hill Education. p. 288. ISBN 978-0-07-182129-2.
  13. ↑ Lauritzen, Christian (1988). "Natürliche und Synthetische Sexualhormone – Biologische Grundlagen und Behandlungsprinzipien" [Natural and Synthetic Sexual Hormones – Biological Basis and Medical Treatment Principles]. In Hermann P. G. Schneider; Christian Lauritzen; Eberhard Nieschlag (eds.). Grundlagen und Klinik der Menschlichen Fortpflanzung [Foundations and Clinic of Human Reproduction] (in German). Walter de Gruyter. pp. 229–306. ISBN 978-3110109689. OCLC 35483492.
  14. ↑ Apotekens informationsavdelning (1964). Apotekens synonymregister över farmacevtiska specialiteter. Apotekens informationsavdelning. Rektandron FERRING supp. 40 mg • individ. dos. • 10 st.


Cite error: <ref> tags exist for a group named "lower-alpha", but no corresponding <references group="lower-alpha"/> tag was found, or a closing </ref> is missing

Retrieved from "https://blackwiki.org/index.php?title=Template:Available_forms_of_testosterone&oldid=2427705"